Wroclaw Out-Of-Hospital Cardiac Arrest Registry (WOHCA)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05132387 |
Recruitment Status :
Recruiting
First Posted : November 24, 2021
Last Update Posted : January 27, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Out-Of-Hospital Cardiac Arrest | Other: ECMO assisted CPR in out-of-hospital cardiac arrest |
Study Type : | Observational [Patient Registry] |
Estimated Enrollment : | 50 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Target Follow-Up Duration: | 1 Month |
Official Title: | Wroclaw Out-Of-Hospital Cardiac Arrest Registry |
Actual Study Start Date : | October 25, 2021 |
Estimated Primary Completion Date : | October 31, 2024 |
Estimated Study Completion Date : | January 1, 2025 |

Group/Cohort | Intervention/treatment |
---|---|
Out-of-hospital cardiac arrest
Patients with out-of-hospital cardiac arrest which occured in the predefined area of the city of Wroclaw.
|
Other: ECMO assisted CPR in out-of-hospital cardiac arrest
Patients included in the registry will be transferred during LUCAS assisted CPR by the Wroclaw Emergency Medical Services to the Emergency Department of the Wroclaw University Hospital where blood gasses will be assessed. If two or more of the following: end-tidal carbon dioxide (CO2) > 10 mm Hg, arterial partial pressure of oxygen (PaO2) >50 mm Hg or oxygen saturation >85%, and lactic acid <18 mmol/L will be fulfilled patient will be further transferred to the Cardiac Catheterization Laboratory for V-A ECMO implantation followed by coronary/pulmonary artery angiography and intervention. |
- mortality [ Time Frame: 1 month ]all cause mortality
- degree of disability [ Time Frame: 3 and 6 months after index event ]Modified Rankin Scale of 3 or lower

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 60 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Age < 60 years
- witnessed sudden cardiac arrest with immediate CPR
- supposed cardiac cause of the event
- ventricular fibrillation (VF) or pulseless ventricular tachycardia (VT) at first medical contact with 3 unsuccessful defibrillations (no ROSC)
- CPR conducted with Lund University Cardiopulmonary Assist System (LUCAS™)
- Estimated transfer time from the scene to the Emergency Department < 30 minutes.
- End tidal carbon dioxide (ETCO2) > 10 mmHg
Exclusion Criteria:
- Total presumed time from 112 call to ECMO implantation longer than 60 minutes
- Age < 18 years old or > 60 years old;
- Non-shockable initial rhythm
- Unavailability of the automated CPR device
- Unavailability of the catheterisation laboratory
- Severe concomitant illness with decreased life expectancy
- Severe body injury
- Severe active bleeding
- Drowning
- Terminal cancer

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05132387
Contact: Wiktor Kuliczkowski, MD | + 48 603 707 093 | wiktor.kuliczkowski@umw.edu.pl |
Poland | |
Wroclaw University Hostpital | Recruiting |
Wroclaw, Poland, 50-556 | |
Contact: Wiktor Kuliczkowski, MD + 48 603707093 wiktor.kuliczkowski@umw.edu.pl |
Principal Investigator: | Wiktor Kuliczkowski, MD | Wroclaw Medical University |
Responsible Party: | Wiktor Kuliczkowski, Head of the Cardiac Catheterisation Laboratory, Wroclaw Medical University |
ClinicalTrials.gov Identifier: | NCT05132387 |
Other Study ID Numbers: |
327/2021 |
First Posted: | November 24, 2021 Key Record Dates |
Last Update Posted: | January 27, 2023 |
Last Verified: | January 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Cardiac arrest, ECMO, ECMO-CPR |
Heart Arrest Out-of-Hospital Cardiac Arrest Heart Diseases Cardiovascular Diseases |